brigham buhler bpc-157 WATCH: FDA advisory panel narrowly backs use of several peptides favored by RFK Jr Brigham Buhler: The Peptide Safety

Brigham Buhler: The Peptide Safety Data Reveals 75,000+ Patients With Zero Adverse Events TUH #182 YouTube The committee votes July 2324. Comments submitted by July 9 go directly to the FDA panel. Your voice matters, Comment HEARING and I'll send you the link. Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Ways2Well Thanks to the LEGEND @joerogan for having Ways2Well founder, Brigham Buhler, on the podcast to talk shop about the broken healthcare system and our WELLNESS REVOLUTION! . . . #wellness #

SKU: 20428161347 · From centoria.fr